-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 15, the launch meeting of "Kehuang Capsule Intervention of Non-Alcoholic Fatty Liver Disease (Damp Heat Intrinsic Syndrome) Multi-center, Randomized Double-blind, Placebo Parallel Control Clinical Trial" was successfully held in Zhengzhou, Hen.
This marks that this project was led by Professor Ji Guang of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine and jointly developed with Sichuan Provincial Hospital of Traditional Chinese Medicine, Foshan Traditional Chinese Medicine Hospital, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Jiaotong University Affiliated Xinhua Hospital, and Henan University of Traditional Chinese Medici.
The clinical research project jointly participated by the affiliated hospitals and other institutions was officially launch.
Director of the Department of Internal Medicine, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Director of the Diagnosis and Treatment Center for Spleen, Stomach, Liver and Gallbladder Diseases, Professor Zhao Wenxia, National Famous Traditional Chinese Medicine Professor, Director of the Scientific Research Department of the hospital Xie Yang, Director of the Gastroenterology Research Group Liu Minghao and the First Affiliated Hospital of Henan University of Traditional Chinese Medicine Kehuang Capsule A total of 24 other researchers from the clinical trial center participated in the meeti.
Expanding the indications of multi-center research It is understood that non-alcoholic fatty liver disease (NAFLD) is a liver metabolic disease, which can gradually progress from simple hepatic steatosis (NAFL) to non-alcoholic steatohepatitis (NAS.
Increased risk of liver fibrosis, cirrhosis, and liver canc.
In recent years, with the improvement of people's living standards and changes in dietary structure, more and more studies have shown that the prevalence of NAFLD continues to increa.
Kehuang Capsule is scientifically formulated with 16 kinds of precious Chinese herbal medicines, including Panax notoginseng, Coptis chinensis, Scutellaria baicalensis, Phellodendron rhizome, rhubarb, artificial bezoar, artificial musk,e.
It has the functions of clearing away heat and detoxifying, protecting the liver and gallbladder, reducing enzymes and reducing jaundice, anti-inflammatory and analgesic, and inhibiting tumo.
Clinical symptoms such as dark red quality and yellow and greasy tongue coating are exclusively produced by Kexing Bio-Pharmaceutical .
,L.
The "14th Five-Year Plan for the Development of Traditional Chinese Medicine" released in March this year clearly stated that it is necessary to build a high-level system of traditional Chinese medicine inheritance, protection and scientific and technological innovati.
Strengthen the clinical efficacy evaluation research of traditional Chinese medicine, and carry out the research and development of new traditional Chinese medicine based on ancient classic prescriptions, famous and old traditional Chinese medicine experience prescriptions, active ingredients or components, e.
At present, some Chinese patent medicines with definite curative effects have been recognized for their role in certain specialized fields, which also guides enterprises to actively carry out relevant clinical verifications, expand relevant indications, and provide more possibilities for alleviating the suffering of patien.
This multi-center randomized double-blind, placebo-controlled clinical trial is also providing an effective basis for the expansion of the indications of Kehuang Capsul.
At present, the project has been registered in the Chinese Clinical Trials Regist.
Professor Zhao Wenxia, as the lead researcher of the Henan branch of this RCT study, expressed great confidence in the proje.
She said that Kehuang Capsules uses the ancient red yeast fermentation process to ferment the drug, and red yeast itself has the effect of preventing and treating fatty liv.
At the same time, Kexing Pharmaceutical has done NAFLD-related pharmacological research in the early stage, which proves that the Huang Capsule has a certain curative effect in the treatment of NAFLD rat mod.
She herself is very much looking forward to the results of the project, and hopes that the R&D team of Kexing Pharmaceuticals will continue to make great contributions to the treatment of fatty liver with traditional Chinese medicine in the futu.
In addition to the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, the clinical trial will soon be conducted in Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Sichuan Provincial Hospital of Traditional Chinese Medicine, Foshan Traditional Chinese Medicine Hospital, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, and Shanghai Jiaotong University Affiliated Xinhua Hospital 5 centers have been launched one after anoth.
A century-old Chinese medicine for protecting the liver and saving the people , Chinese medicine has thousands of years of human clinical application experien.
In the prevention and treatment of complex chronic diseases, traditional Chinese medicine has always been highly sought after by the people because it pays more attention to the overall benefit of patien.
Artemisinin, berberine, ephedrine and other traditional Chinese medicines that are familiar to the public also provide clues and support for modern drug developme.
As a famous folk prescription, Kehuang Capsule also has a history of a hundred yea.
Legend has it that in 1867 (the period of Tongzhi in the Qing Dynasty), the Shaolin Temple in Quanzhou, Fujian, made a secret elixir for the treatment of internal and external injuries that occurred when monks practiced Qigo.
In 1927, when the Quanzhou Plague was prevalent, Indonesian overseas Chinese donated medicines in Huaqiao Pavilion, Quanzhou, and accidentally discovered that this medicine has the magical effect of clearing away heat and swelling, and was amazed! It is named "Ke Huang", Huang is Hokkien, which means various heat toxins, swelling and pain, and Kehuang means restraining all kinds of heat toxins, swelling, pain and inflammati.
Later, through the hands of overseas Chinese in Indonesia, Ke Huang has been spread to Hong Kong, Taiwan and Southeast Asia and other places one after another, and has been highly prais.
But at that time, Kehuang was a fragrance outside the wal.
It was not until the outbreak of hepatitis A in Shanghai in 1988 that Kehuang stood out among many drugs because of its excellent effects of reducing jaundice, reducing enzymes and protecting liv.
Concerns from the medical, academic and business secto.
In 1994, Kehuang Capsules obtained the National New Drug Certifica.
In 1995, Kehuang Capsules were included in the National Spark Progr.
In 1996, Kehuang Capsules were approved for production and officially listed in the Mainla.
As an exclusive Chinese patent medicine and a national patented product, Kehuang Capsule has been on the market for more than 20 years and has been well received by domestic clinicians and patien.
In recent years, the state has launched a series of favorable policy suppo.
For example, in the Outline of the Strategic Plan for the Development of Traditional Chinese Medicine (2016-2030) issued by the State Council, the development of traditional Chinese medicine is placed at an important position in the overall economic and social developme.
The "Traditional Chinese Medicine Law", which was implemented in July 2017, pointed out that the state takes measures to support the sorting, research and utilization of ancient Chinese medicine books and documents, the academic thoughts and diagnosis and treatment experience of famous Chinese medicine experts, and folk traditional Chinese medicine techniqu.
In addition, according to data from the China Business Industry Research Institute, the scale of Chinese patent medicine manufacturing in China may reach more than 70 billion and grow year by ye.
According to the data of the National Development and Reform Commission, the main business income of Chinese patent medicine production has reached nearly 600 billi.
Relevant data also show that in recent years, liver disease has shown a trend of younger peop.
In addition, there have been many cases of acute hepatitis in children of unknown cause in overseas countries recently, and the prevention and treatment of liver disease has once again attracted attenti.
In the post-"COVID-19" era, standing at a higher historical starting point, with the further improvement of doctors and patients' acceptance of traditional Chinese medicine and the country's attention, traditional Chinese medicine may usher in a huge Potential market!Expansion of indications, multi-center research,century-old Chinese medicine to protect the liver and save the people[Kunming Optical Shop] Knowing these 8 glasses is enough!Steady Medical's 750 million yuan holding Ping An Medical Equipment enters the new track of injection and puncture category
This marks that this project was led by Professor Ji Guang of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine and jointly developed with Sichuan Provincial Hospital of Traditional Chinese Medicine, Foshan Traditional Chinese Medicine Hospital, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Jiaotong University Affiliated Xinhua Hospital, and Henan University of Traditional Chinese Medici.
The clinical research project jointly participated by the affiliated hospitals and other institutions was officially launch.
Director of the Department of Internal Medicine, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Director of the Diagnosis and Treatment Center for Spleen, Stomach, Liver and Gallbladder Diseases, Professor Zhao Wenxia, National Famous Traditional Chinese Medicine Professor, Director of the Scientific Research Department of the hospital Xie Yang, Director of the Gastroenterology Research Group Liu Minghao and the First Affiliated Hospital of Henan University of Traditional Chinese Medicine Kehuang Capsule A total of 24 other researchers from the clinical trial center participated in the meeti.
Expanding the indications of multi-center research It is understood that non-alcoholic fatty liver disease (NAFLD) is a liver metabolic disease, which can gradually progress from simple hepatic steatosis (NAFL) to non-alcoholic steatohepatitis (NAS.
Increased risk of liver fibrosis, cirrhosis, and liver canc.
In recent years, with the improvement of people's living standards and changes in dietary structure, more and more studies have shown that the prevalence of NAFLD continues to increa.
Kehuang Capsule is scientifically formulated with 16 kinds of precious Chinese herbal medicines, including Panax notoginseng, Coptis chinensis, Scutellaria baicalensis, Phellodendron rhizome, rhubarb, artificial bezoar, artificial musk,e.
It has the functions of clearing away heat and detoxifying, protecting the liver and gallbladder, reducing enzymes and reducing jaundice, anti-inflammatory and analgesic, and inhibiting tumo.
Clinical symptoms such as dark red quality and yellow and greasy tongue coating are exclusively produced by Kexing Bio-Pharmaceutical .
,L.
The "14th Five-Year Plan for the Development of Traditional Chinese Medicine" released in March this year clearly stated that it is necessary to build a high-level system of traditional Chinese medicine inheritance, protection and scientific and technological innovati.
Strengthen the clinical efficacy evaluation research of traditional Chinese medicine, and carry out the research and development of new traditional Chinese medicine based on ancient classic prescriptions, famous and old traditional Chinese medicine experience prescriptions, active ingredients or components, e.
At present, some Chinese patent medicines with definite curative effects have been recognized for their role in certain specialized fields, which also guides enterprises to actively carry out relevant clinical verifications, expand relevant indications, and provide more possibilities for alleviating the suffering of patien.
This multi-center randomized double-blind, placebo-controlled clinical trial is also providing an effective basis for the expansion of the indications of Kehuang Capsul.
At present, the project has been registered in the Chinese Clinical Trials Regist.
Professor Zhao Wenxia, as the lead researcher of the Henan branch of this RCT study, expressed great confidence in the proje.
She said that Kehuang Capsules uses the ancient red yeast fermentation process to ferment the drug, and red yeast itself has the effect of preventing and treating fatty liv.
At the same time, Kexing Pharmaceutical has done NAFLD-related pharmacological research in the early stage, which proves that the Huang Capsule has a certain curative effect in the treatment of NAFLD rat mod.
She herself is very much looking forward to the results of the project, and hopes that the R&D team of Kexing Pharmaceuticals will continue to make great contributions to the treatment of fatty liver with traditional Chinese medicine in the futu.
In addition to the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, the clinical trial will soon be conducted in Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Sichuan Provincial Hospital of Traditional Chinese Medicine, Foshan Traditional Chinese Medicine Hospital, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, and Shanghai Jiaotong University Affiliated Xinhua Hospital 5 centers have been launched one after anoth.
A century-old Chinese medicine for protecting the liver and saving the people , Chinese medicine has thousands of years of human clinical application experien.
In the prevention and treatment of complex chronic diseases, traditional Chinese medicine has always been highly sought after by the people because it pays more attention to the overall benefit of patien.
Artemisinin, berberine, ephedrine and other traditional Chinese medicines that are familiar to the public also provide clues and support for modern drug developme.
As a famous folk prescription, Kehuang Capsule also has a history of a hundred yea.
Legend has it that in 1867 (the period of Tongzhi in the Qing Dynasty), the Shaolin Temple in Quanzhou, Fujian, made a secret elixir for the treatment of internal and external injuries that occurred when monks practiced Qigo.
In 1927, when the Quanzhou Plague was prevalent, Indonesian overseas Chinese donated medicines in Huaqiao Pavilion, Quanzhou, and accidentally discovered that this medicine has the magical effect of clearing away heat and swelling, and was amazed! It is named "Ke Huang", Huang is Hokkien, which means various heat toxins, swelling and pain, and Kehuang means restraining all kinds of heat toxins, swelling, pain and inflammati.
Later, through the hands of overseas Chinese in Indonesia, Ke Huang has been spread to Hong Kong, Taiwan and Southeast Asia and other places one after another, and has been highly prais.
But at that time, Kehuang was a fragrance outside the wal.
It was not until the outbreak of hepatitis A in Shanghai in 1988 that Kehuang stood out among many drugs because of its excellent effects of reducing jaundice, reducing enzymes and protecting liv.
Concerns from the medical, academic and business secto.
In 1994, Kehuang Capsules obtained the National New Drug Certifica.
In 1995, Kehuang Capsules were included in the National Spark Progr.
In 1996, Kehuang Capsules were approved for production and officially listed in the Mainla.
As an exclusive Chinese patent medicine and a national patented product, Kehuang Capsule has been on the market for more than 20 years and has been well received by domestic clinicians and patien.
In recent years, the state has launched a series of favorable policy suppo.
For example, in the Outline of the Strategic Plan for the Development of Traditional Chinese Medicine (2016-2030) issued by the State Council, the development of traditional Chinese medicine is placed at an important position in the overall economic and social developme.
The "Traditional Chinese Medicine Law", which was implemented in July 2017, pointed out that the state takes measures to support the sorting, research and utilization of ancient Chinese medicine books and documents, the academic thoughts and diagnosis and treatment experience of famous Chinese medicine experts, and folk traditional Chinese medicine techniqu.
In addition, according to data from the China Business Industry Research Institute, the scale of Chinese patent medicine manufacturing in China may reach more than 70 billion and grow year by ye.
According to the data of the National Development and Reform Commission, the main business income of Chinese patent medicine production has reached nearly 600 billi.
Relevant data also show that in recent years, liver disease has shown a trend of younger peop.
In addition, there have been many cases of acute hepatitis in children of unknown cause in overseas countries recently, and the prevention and treatment of liver disease has once again attracted attenti.
In the post-"COVID-19" era, standing at a higher historical starting point, with the further improvement of doctors and patients' acceptance of traditional Chinese medicine and the country's attention, traditional Chinese medicine may usher in a huge Potential market!Expansion of indications, multi-center research,century-old Chinese medicine to protect the liver and save the people[Kunming Optical Shop] Knowing these 8 glasses is enough!Steady Medical's 750 million yuan holding Ping An Medical Equipment enters the new track of injection and puncture category
